Cullinan Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: CGEM

Cullinan Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker CGEM.

Profile compiled from public records. Is this your company? Request a correction or update

Cullinan Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Stock listingNasdaq: CGEM

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1789972

Frequently asked questions about Cullinan Therapeutics

Where is Cullinan Therapeutics headquartered?

Cullinan Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Cullinan Therapeutics do?

Cullinan Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Cullinan Therapeutics a public company?

Yes. Cullinan Therapeutics, Inc. trades on Nasdaq under the ticker CGEM.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences